In the UK the FTSE 100 Index continues its poor run, shedding a further 20 points this morning to 5272.50, led by Royal Dutch Shell.
The "A" ordinary shares of the firm have slipped 36p to 1847p on the back of waning crude prices, along with its "B" shares down 28p to 1782p. Mining firm Antofagasta has also dropped 322p to 1382p, along with Xstrata falling 19p to 1272p. On the winning side, Shire Pharmaceuticals has profited 25p or 4% to 664.5p on speculation that Barr Pharmaceuticals will agree to withdraw its patent challenge against hyperactivity treatment Adderall XR, Shire's best-selling drug. Royal Bank of Scotland meanwhile, has picked up 33p to 1640p, after announcing it is part of a consortium planning to ...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
